Aspirin Complex: Cold and flu relief with decongestant punch
12.06.2026 - 12:08:14 | ad-hoc-news.de
Responsible: ad hoc news Lifestyle & Consumer Desk. Reviewed prior to publication on June 12, 2026 at 12:07:21 PM ET. Details in the imprint.
Aspirin Complex is Bayer's combination cold product that pairs the well known pain reliever acetylsalicylic acid with a nasal decongestant in granules designed to be dissolved in hot water, positioned as an over-the-counter option for adults with colds or flu-like infections featuring fever, headache, and a blocked nose. The product contains acetylsalicylic acid and pseudoephedrine hydrochloride in a sachet format, and is marketed in several European countries as a pharmacy-only medicine for short term use in acute upper respiratory infections. While Aspirin-branded products are broadly known in the United States, this specific Aspirin Complex formulation is primarily documented for European markets, so U.S. shoppers will mainly encounter it through international listings rather than mainstream U.S. retail shelves. For consumers looking at Bayer's cold and pain portfolio as a whole, Aspirin Complex sits alongside classic Aspirin tablets and other cold remedies that address overlapping symptoms with different active-ingredient profiles.
What Aspirin Complex is designed to do
Aspirin Complex is formulated to treat several typical cold and flu symptoms at once: pain such as headache or sore throat, elevated temperature, and nasal congestion caused by swollen mucous membranes. Acetylsalicylic acid belongs to the non-steroidal anti-inflammatory drugs (NSAIDs) and inhibits prostaglandin synthesis, which is associated with reduced pain and fever. Pseudoephedrine is a sympathomimetic that causes vasoconstriction in the nasal mucosa, which can shrink swollen nasal passages and ease breathing through the nose. According to Bayer's product information, the granules are dissolved in hot water and taken as a warm drink, which differentiates Aspirin Complex from simple tablets or capsules in terms of user experience and may appeal to patients who prefer hot beverages when they have a cold.
The indicated use generally covers adults and adolescents above a defined age threshold, with dosage limits on how many sachets may be taken per day and for how many days in a row. Package information highlights that the product is intended for short term symptom relief during an acute infection rather than long term therapy. Contraindications typically include known hypersensitivity to acetylsalicylic acid or other NSAIDs, a history of certain gastrointestinal ulcers, severe cardiovascular disease, and specific conditions where vasoconstrictors like pseudoephedrine are not recommended, such as severe hypertension. As with other aspirin-containing products, warnings about use in children with viral infections due to the risk of Reye's syndrome are standard, and the labeling advises patients to consult a physician or pharmacist before use if they have chronic illnesses or take other medicines.
Positioning, packaging, and availability
Aspirin Complex is commonly sold in packs of single dose sachets of granules, with pack sizes such as 10 or 20 sachets depending on the market. In European pharmacy channels, it is often displayed in the cold and flu section alongside nasal sprays, paracetamol-based remedies, and other multi-symptom products that combine analgesics with decongestants or antihistamines. The Aspirin branding leverages Bayer's long standing association with acetylsalicylic acid, while the "Complex" label signals the multi-symptom positioning and addition of pseudoephedrine. The product is generally available without a prescription but restricted to pharmacy sale, reflecting the presence of pseudoephedrine, which is regulated in many jurisdictions due to potential misuse.
List prices for Aspirin Complex vary by country, retailer, and pack size, and Bayer's materials emphasize that final consumer prices are set by pharmacies and other sellers rather than centrally by the manufacturer. For U.S.-based consumers, the product may appear on international online marketplaces that ship European medicines, but Bayer's mainstream U.S. consumer health portfolio focuses instead on products like Alka-Seltzer, Claritin, and U.S.-marketed Aspirin, which occupy similar symptom-relief spaces with formulations aligned to U.S. regulatory frameworks. From a portfolio viewpoint, Aspirin Complex represents Bayer's strategy of extending the Aspirin brand into adjacent indications such as cold and flu, offering a recognizable name in a crowded over-the-counter segment that includes many private-label and branded competitors combining pain relief with decongestants.
Analysts and industry observers often note that Bayer's consumer health business, which includes the Aspirin franchise, contributes a stable revenue stream alongside the more cyclical and patent-dependent pharmaceuticals division. Shares of Bayer AG (DE000BAY0017, ticker BAYRY) last traded around $6.50 as an American depositary receipt on OTC markets on June 11, 2026.
Snapshot: Aspirin Complex
- Product: Aspirin Complex
- Manufacturer: Bayer AG
- Category: Lifestyle/consumer cold and flu remedy
- Launch date: Documented in European markets as an established product; specific first launch year not clearly stated in public materials.
- MSRP / Price: Varies by European country and pack size; pharmacy retail product with final price set by retailers.
- Availability: Pharmacy-only over-the-counter product in several European markets; limited availability for U.S. consumers mainly via international online sellers.
- Target audience: Adults and adolescents needing short term relief from cold and flu symptoms such as headache, fever, and nasal congestion.
- Key feature / USP: Combines acetylsalicylic acid and pseudoephedrine in hot-water granules to address pain, fever, and nasal congestion in one product.
More background on Bayer AG
For readers following Bayer's broader health portfolio beyond Aspirin Complex, additional updates, financial reports, and product news are collected in the dedicated Bayer AG topic section and in the company's investor materials.
More Bayer AG news Investor RelationsThis article was created with a.i. assistance and editorially reviewed. Product information is provided without warranty; prices and availability may change at any time. Not investment advice, not a buy or sell recommendation. Trading in securities carries risks up to the total loss of capital.
